Effect of Qizhu capsules combined with maintenance hemodialysis on iron metabolism-related indicators in patients with diabetic kidney disease complicated by renal anemia
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
ObjectiveTo analyze the effects of Qizhu capsules plus maintenance hemodialysis on inflammatory markers and iron metabolism-related indicators in patients with diabetic kidney disease complicated by renal anemia.MethodsFrom April 5, 2022, to December 5, 2022, 120 patients with type 2 diabetic kidney disease and renal anemia admitted to Langfang Hospital of Traditional Chinese Medicine were enrolled and randomized by a random number table into a control group and a treatment group (60 patients each). The control group received dietary control, routine symptomatic treatment, and hemodialysis. The treatment group received the same regimen plus Qizhu capsules. Liver and renal function, inflammatory markers, erythropoietin (EPO), and iron metabolism-related indicators were compared before treatment, at week 4, and after treatment. Clinical efficacy after treatment was recorded.ResultsLiver function: There was no interaction between group and time for alanine aminotransferase(ALT) and aspartate aminotransferase(AST) (P>0.05). Intergroup comparisons of ALT [baseline: (31.64±12.59) U/L vs (32.58±11.17) U/L; week 4: (28.41±4.43) U/L vs (29.76±4.80) U/L; after treatment: (25.66±5.32) U/L vs (27.04±5.95) U/L] and AST[baseline: (28.83±8.49) U/L vs (28.11±8.62) U/L; week 4: (25.06±6.78) U/L vs (26.93±6.57) U/L; after treatment: (23.40±5.24) U/L vs (24.88± 5.61) U/L] reached statistical significance, while the time effect on ALT and AST was not significant (P>0.05). Renal function: There was no interaction between group and time for blood urea nitrogen (BUN) (P>0.05), whereas serum creatinine (Scr) showed a significant group× time interaction (P
Fields of Study & Subjects
Erythropoietin and Anemia Treatment
Iron Metabolism and Disorders
Dialysis and Renal Disease Management
Publication details
- Journal / source
- DOAJ (DOAJ: Directory of Open Access Journals)
- Publication date
- 1 January 2026
- Language
- ZH